Ischemic Stroke News and Research

RSS

Identification of gaps in accessing stroke centers cuts down the deadly toll of stroke

When stroke strikes, choking off blood supply to the brain, every minute counts: Nearly 2 million neurons die each minute a stroke is left untreated, making it a race to recognize symptoms so that lifesaving "clot-busting" drugs can be administered.

25 Feb 2010

Arterial ischemic stroke in children often go unrecognized, and the strokes can recur

Children can have strokes, and the strokes can recur, usually within a month, according to pediatric researchers. Unfortunately, the strokes often go unrecognized the first time, and the child does not receive treatment before the recurrence.

25 Feb 2010

Nearly 40% of TIA and minor ischemic stroke patients may experience mental impairment

Nearly four in 10 transient ischemic attack (TIA) and minor ischemic stroke patients may experience mental impairment, according to a study presented at the American Stroke Association's International Stroke Conference 2010.

25 Feb 2010

Study examines associations of different fats and subtypes of ischemic stroke in post-menopausal women

Post-menopausal women who reported consuming the most daily dietary fat had a 40 percent higher incidence of clot-caused strokes compared to women who ate the least amount, according to research presented at the American Stroke Association's International Stroke Conference 2010.

25 Feb 2010

Acute stroke care and clinical outcomes improve substantially with stroke program

Acute stroke care and clinical outcomes have improved significantly at hospitals participating in the American Heart Association/American Stroke Association's Get With The Guidelines-Stroke program, according to a large study in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

23 Feb 2010

CoAxia completes enrollment in NeuroFlo Perfusion Augmentation Therapy trial for ischemic stroke

CoAxia™, Inc. of Maple Grove, MN, announced today the completion of enrollment in its SENTIS randomized, controlled, pivotal trial of NeuroFlo™ Perfusion Augmentation Therapy as an acute interventional treatment for ischemic stroke. The Company plans to complete data collection and analysis of results in Q3 of 2010 and, if warranted, submit a PMA to the US FDA.

15 Feb 2010

Age-related gaps in care and outcomes for stroke patients are diminishing in hospitals

Age-related gaps in care and outcomes for stroke patients are diminishing as hospitals improve adherence to evidence-based treatments of the American Heart Association/American Stroke Association's Get With The Guidelines–Stroke initiative, according to a new study in Circulation: Journal of the American Heart Association.

10 Feb 2010

Concentric Medical's Trevo System receives regulatory approval in Europe and Canada

Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that its Trevo System for acute ischemic stroke has received regulatory approval in both Europe (CE Mark) and Canada.

10 Feb 2010

PLX cell therapy may be an effective treatment for ischemic stroke disorder

Pluristem Therapeutics Inc. today announced that the results of a pre-clinical study in an animal model of ischemic stroke demonstrated that its PLacental eXpanded (PLX) cell therapy may be an effective treatment for this disorder.

4 Feb 2010

Evidence suggests antidepressants may improve post-stroke recovery

Patients who received the antidepressant escitalopram following a stroke appeared to recover more of their thinking, learning and memory skills than those taking placebo or participating in problem-solving therapy, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Feb 2010

Concentric Medical reports first use of its Trevo System for acute ischemic stroke in Europe

Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo™ System in Europe. The Trevo System is an innovative, high performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is a stentriever™, a new generation of retrieval devices which removes clots that cause stroke.

12 Jan 2010

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

EKR Therapeutics, Inc., a specialty pharmaceutical company commercializing acute-care hospital products, today said that interim study data1 demonstrate that Cardene® I.V. (nicardipine hydrochloride) is significantly more effective than intravenous labetalol for the management of blood pressure (BP) in stroke patients.

12 Jan 2010

D-Pharm commences enrollment in MACSI Phase III clinical study for acute ischemic stroke

D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).

3 Jan 2010

Specialists On Call achieves telemedicine milestone

Specialists On Call, Inc. (SOC), announced today that it recently delivered its 10,000th emergency teleneurology consultation since the company's inception. This telemedicine milestone is an unprecedented achievement and expands SOC's leadership position as the largest private emergency teleneurology provider in the country.

22 Dec 2009

RRE-90 score: A new web-based tool to predict recurrent stroke risk

Scientists have developed a new web-based tool that may better predict whether a person will suffer a second stroke within 90 days of a first stroke, according to research published in the December 16, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.

17 Dec 2009

Study shows younger, female and Hispanic stroke survivors are less likely to take antithrombotic medications

People who have had an ischemic stroke are at higher lifetime risk for another stroke, but several types of medication can reduce that risk. One of the simplest regimens involves antithrombotic medications, otherwise known as blood thinners, of which the most common is aspirin.

3 Dec 2009

AmKor and Hengdian Group sign license agreement to develop and market new drug candidate in China

AmKor (AmKor Pharma, Inc.) and Hengdian Group (Hengdian Group Ltd) today announced the signing of licensing agreement for further development and commercialization of Neu2000 in China.

24 Nov 2009

Study: Men who do moderate-to-heavy intensity exercise are less likely to have stroke

Men who regularly take part in moderate-to-heavy intensity exercise such as jogging, tennis or swimming may be less likely to have a stroke than people who get no exercise or only light exercise, such as walking, golfing, or bowling, according to a study published in the November 24, 2009, print issue of Neurology ®, the medical journal of the American Academy of Neurology.

24 Nov 2009

Texas Court dismisses all claims against Merck in VIOXX-related lawsuit

Merck said today that Travis County, Texas District Court Judge Scott H. Jenkins granted Merck's motion for summary judgment, dismissing all claims in a VIOXX-related lawsuit filed on behalf of the State of Texas.

23 Nov 2009

Drug market for acute ischemic stroke to reach $450M in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales of agents to treat acute ischemic stroke will remain relatively flat over the next decade, increasing from $360 million in 2008 to $450 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

18 Nov 2009

Ischemic Stroke News and Research

Identification of gaps in accessing stroke centers cuts down the deadly toll of stroke

Arterial ischemic stroke in children often go unrecognized, and the strokes can recur

Nearly 40% of TIA and minor ischemic stroke patients may experience mental impairment

Study examines associations of different fats and subtypes of ischemic stroke in post-menopausal women

Acute stroke care and clinical outcomes improve substantially with stroke program

CoAxia completes enrollment in NeuroFlo Perfusion Augmentation Therapy trial for ischemic stroke

Age-related gaps in care and outcomes for stroke patients are diminishing in hospitals

Concentric Medical's Trevo System receives regulatory approval in Europe and Canada

PLX cell therapy may be an effective treatment for ischemic stroke disorder

Evidence suggests antidepressants may improve post-stroke recovery

Concentric Medical reports first use of its Trevo System for acute ischemic stroke in Europe

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

D-Pharm commences enrollment in MACSI Phase III clinical study for acute ischemic stroke

Specialists On Call achieves telemedicine milestone

RRE-90 score: A new web-based tool to predict recurrent stroke risk

Study shows younger, female and Hispanic stroke survivors are less likely to take antithrombotic medications

AmKor and Hengdian Group sign license agreement to develop and market new drug candidate in China

Study: Men who do moderate-to-heavy intensity exercise are less likely to have stroke

Texas Court dismisses all claims against Merck in VIOXX-related lawsuit

Drug market for acute ischemic stroke to reach $450M in 2018

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News